Webinar
Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session
SHARE
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration, is accepting letters of intent now through Wednesday, November 4, 2026, for its fourth round of funding. Funded projects will be eligible for up to $500,000 over two years, inclusive of indirect costs.
The grant program aims to accelerate basic discoveries, introduce novel research approaches, and, ultimately, improve patient outcomes for people living with FTD. A broad range of topics is responsive to this call.
An informal informational webinar for interested applicants will be held on Tuesday, October 13, 2026, at 11 a.m. US Eastern Time (8 a.m. Pacific Time; 5 p.m. Central European Time). Attendees must register using this Zoom registration link.
The recorded webinar will be hosted on this page after its conclusion.
Interested applicants should apply for the grant program’s fourth round of funding by submitting a letter of intent by November 4, 2026, at 11:59 p.m. US Eastern Time. Please see the full 2026–2027 Request for Proposals for additional information.
SHARE
Related Content
-
Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program (2026–2027)
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund the fourth annual cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop.Read Article -
The Global Brain Care Coalition: A Model to Put Brain Science into Action
It takes an average of 17 years for a scientific discovery to travel from the lab to clinical practice. In brain health, that delay has a real cost as the global population ages and more people face conditions such as dementia, stroke, and...Read Report
-
Request for Proposals: Ann Theodore Foundation Sarcoidosis Inhibitor of mTOR (SIM) Trial
The Ann Theodore Foundation (ATF) is launching a new funding program to support the study of repurposed mechanistic target of rapamycin (mTOR) inhibitors as treatments for cutaneous sarcoidosis. This program will be executed in partnership...Read Article -
Milken Institute, Ann Theodore Foundation Launch New Grant to Support Clinical Trial for Potential Sarcoidosis Treatment
February 20, 2026 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future...Read Article -
Uterine Leiomyosarcoma: A Giving Smarter Guide
This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...Read ReportIM
-
Request for Proposals: Misophonia
The Misophonia Research Fund is pleased to release the 2023 Request for Proposals. The General Grant Program RFP is soliciting research proposals that aim to characterize misophonia, develop objective methods to assess misophonia, or...Read Article -
Misophonia - A Giving Smarter Guide
While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...Read ReportJR
-
Anxiety: A Giving Smarter Guide
Anxiety is a natural and adaptive emotion that promotes vigilance against potential threats. However, anxiety that persists or is disproportionate to actual risk becomes dysfunctional and can impair daily functioning.Read ReportIM